Blennow K - Search Results

1

Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain.

Alcolea D, Martínez-Lage P, Izagirre A, Clerigué M, Carmona-Iragui M, Alvarez RM, Fortea J, Balasa M, Morenas-Rodríguez E, Lladó A, Grau O, Blennow K, Lleó A, Molinuevo JL. Alcolea D, et al. Among authors: blennow k. J Alzheimers Dis. 2014;39(4):719-26. doi: 10.3233/JAD-131334. J Alzheimers Dis. 2014. PMID: 24254700

2

Differences in cerebrospinal fluid gangliosides between "probable Alzheimer's disease" and normal aging.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Månsson JE, Svennerholm L. Blennow K, et al. Aging (Milano). 1992 Dec;4(4):301-6. Aging (Milano). 1992. PMID: 1294245

3

Gangliosides in cerebrospinal fluid in 'probable Alzheimer's disease'.

Blennow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Månsson JE, Svennerholm L. Blennow K, et al. Arch Neurol. 1991 Oct;48(10):1032-5. doi: 10.1001/archneur.1991.00530220048018. Arch Neurol. 1991. PMID: 1929894

4

Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors.

Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L. Blennow K, et al. Acta Neurol Scand. 1990 Apr;81(4):323-6. doi: 10.1111/j.1600-0404.1990.tb01563.x. Acta Neurol Scand. 1990. PMID: 2360400

5

Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.

Bråne G, Gottfries CG, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A. Bråne G, et al. Among authors: blennow k. Alzheimer Dis Assoc Disord. 1989 Fall;3(3):148-56. doi: 10.1097/00002093-198903030-00004. Alzheimer Dis Assoc Disord. 1989. PMID: 2477044

6

Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.

Blennow K, Hesse C, Fredman P. Blennow K, et al. Neuroreport. 1994 Dec 20;5(18):2534-6. doi: 10.1097/00001756-199412000-00032. Neuroreport. 1994. PMID: 7696597

7

Neuron specific enolase in cerebrospinal fluid: a biochemical marker for neuronal degeneration in dementia disorders?

Blennow K, Wallin A, Ekman R. Blennow K, et al. J Neural Transm Park Dis Dement Sect. 1994;8(3):183-91. doi: 10.1007/BF02260939. J Neural Transm Park Dis Dement Sect. 1994. PMID: 7748462

8

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

Blennow K, Davidsson P, Wallin A, Gottfries CG, Svennerholm L. Blennow K, et al. Int Psychogeriatr. 1994 Spring;6(1):13-22; discussion 59-60. doi: 10.1017/s1041610294001584. Int Psychogeriatr. 1994. PMID: 8054491

9

Low frequency of post-lumbar puncture headache in demented patients.

Blennow K, Wallin A, Häger O. Blennow K, et al. Acta Neurol Scand. 1993 Sep;88(3):221-3. doi: 10.1111/j.1600-0404.1993.tb04221.x. Acta Neurol Scand. 1993. PMID: 8256560

10

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia.

Heilig M, Sjögren M, Blennow K, Ekman R, Wallin A. Heilig M, et al. Among authors: blennow k. Biol Psychiatry. 1995 Aug 15;38(4):210-6. doi: 10.1016/0006-3223(94)00239-Y. Biol Psychiatry. 1995. PMID: 8547442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,221 results

Search Page

Filters